Citigroup Inc Crispr Therapeutics Ag Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Citigroup Inc holds 126,892 shares of CRSP stock, worth $6.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

126,892

Previous 205,648 38.3%

Holding current value

$6.99 Million

Previous $7 Million 11.8%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$31.27 - $48.64 $2.46 Million - $3.83 Million	-78,756 Reduced 38.3%	126,892 $6.17 Million
Q1 2025 May 12, 2025	BUY	$34.03 - $53.02 $3.24 Million - $5.05 Million	95,292 Added 86.35%	205,648 $7 Million
Q4 2024 Feb 12, 2025	BUY	$38.65 - $55.15 $3.32 Million - $4.74 Million	85,934 Added 351.87%	110,356 $4.34 Million
Q3 2024 Nov 12, 2024	SELL	$44.62 - $62.75 $610,490 - $858,545	-13,682 Reduced 35.91%	24,422 $1.15 Million
Q2 2024 Aug 12, 2024	SELL	$51.17 - $68.18 $3.24 Million - $4.32 Million	-63,365 Reduced 62.45%	38,104 $2.06 Million
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $583,402 - $856,977	-9,616 Reduced 8.66%	101,469 $6.92 Million
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $39,624 - $74,056	-1,026 Reduced 0.92%	111,085 $6.95 Million
Q3 2023 Nov 09, 2023	BUY	$45.39 - $59.0 $164,175 - $213,403	3,617 Added 3.33%	112,111 $5.09 Million
Q2 2023 Aug 10, 2023	SELL	$43.47 - $67.77 $3.59 Million - $5.59 Million	-82,521 Reduced 43.2%	108,494 $6.09 Million
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $2.71 Million - $3.71 Million	66,067 Added 52.88%	191,015 $8.64 Million
Q4 2022 Feb 09, 2023	BUY	$39.19 - $65.67 $327,393 - $548,607	8,354 Added 7.17%	124,948 $5.08 Million
Q3 2022 Nov 10, 2022	BUY	$61.1 - $83.78 $1.55 Million - $2.12 Million	25,340 Added 27.77%	116,594 $7.62 Million
Q2 2022 Aug 10, 2022	BUY	$43.23 - $73.83 $2.63 Million - $4.49 Million	60,876 Added 200.4%	91,254 $5.55 Million
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $21,807 - $32,488	-410 Reduced 1.33%	30,378 $1.91 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $159,454 - $253,184	2,275 Added 7.98%	30,788 $2.33 Million
Q3 2021 Nov 10, 2021	BUY	$110.2 - $156.64 $3.14 Million - $4.47 Million	28,513 New	28,513 $3.19 Million

Others Institutions Holding CRSP

# of Institutions

540

Shares Held

69M

Call Options Held

3.66M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.3B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account